Search

Search Constraints

You searched for: Author/Creator Shulman, Nancy S.

Search Results

1. DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha‐2a/ribavirin in HCV genotypes 1 or 4. (12th February 2014)

2. Dynamic changes in innate immune responses during direct‐acting antiviral therapy for HCV infection. Issue 3 (3rd January 2019)

3. Effect of Baseline Resistance‐Associated Variants on SVR with the 3D Regimen with and without RBV in GT1a and GT1b‐Infected Patients: 854. (October 2016)

4. Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection. Issue 4 (25th July 2018)

5. Mericitabine and ritonavir‐boosted danoprevir with or without ribavirin in treatment‐naive HCV genotype 1 patients: INFORM‐SVR study. (19th June 2014)

6. Ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin for chronic hepatitis C virus genotype 1b-infected cirrhotics (TURQUOISE-IV). Issue 9 (September 2018)